We are proud to be selected for #digitalbiomarker research in this year's @Target ALS & @Alzheimer's Drug Discovery Foundation initiative.

PROSA - A prognostic low-stress digital language biomarker to improve future ALS and FTD studies. This research will help to distinguish between the causes of language changes in ALS and FTD patients in language disorders (cognition), speech motor disorders and breathing disorders using a simple voice test via telephone.

https://www.prnewswire.com/news-releases/target-als-and-alzheimers-drug-discovery-foundation-announce-award-recipients-for-biomarker-research-301610201.html

Consortium: @Johanne Tröger (@ki elements), @JessicaRobin (@WLL ), Anja Schneider & Andreas Hermann (@DZNE)

Many thanks to @Manish Raisinghani (Target ALS) & @Sarah Giardina (ADDF)